Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults

INTRODUCTION: Dupilumab significantly improves signs and symptoms of atopic dermatitis (AD), including pruritus, symptoms of anxiety and depression, and health-related quality of life versus placebo in adults with moderate-to-severe AD. Since the cost-effectiveness of dupilumab has not been evaluate...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Dermatol Ther (Heidelb)
Κύριοι συγγραφείς: Kuznik, Andreas, Bégo-Le-Bagousse, Gaëlle, Eckert, Laurent, Gadkari, Abhijit, Simpson, Eric, Graham, Christopher N., Miles, LaStella, Mastey, Vera, Mahajan, Puneet, Sullivan, Sean D.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Springer Healthcare 2017
Θέματα:
Original Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698200/
https://ncbi.nlm.nih.gov/pubmed/28933010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-017-0201-6
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια